Progress of Biomarkers to Predict Response to Immune Checkpoint Inhibitors in Microsatellite Stability Colorectal Cancer / 肿瘤防治研究
Cancer Research on Prevention and Treatment
; (12): 186-190, 2023.
Article
ي Zh
| WPRIM
| ID: wpr-986701
المكتبة المسؤولة:
WPRO
ABSTRACT
The exploration of biomarkers predicting response to immune checkpoint inhibitors in microsatellite stability colorectal cancer can enable more patients to benefit from immunotherapy. Tumor mutational burden (TMB), POLE/POLD1 mutation, CMS classifications, MGMT methylation, and other indicators own the potential and value of predicting response to immune checkpoint inhibitors in microsatellite stability colorectal cancer. In this paper, we reviewed the related research on predictive biomarkers of immune checkpoint inhibitors in microsatellite stability colorectal cancer, provide a reference for the best treatment strategy for microsatellite stability colorectal cancer.
النص الكامل:
1
الفهرس:
WPRIM
اللغة:
Zh
مجلة:
Cancer Research on Prevention and Treatment
السنة:
2023
نوع:
Article